Dermatology
Dupixent Samples for Healthcare Providers
Explore medication sample resources and treatment access support for clinicians prescribing Dupixent® (dupilumab injection).
Dupixent® (dupilumab) is a biologic therapy indicated for multiple conditions associated with type 2 inflammation, including certain patients with atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, and other approved indications. It is administered by subcutaneous injection and may be prescribed as part of a long-term disease management strategy. Dupixent® targets key inflammatory pathways involved in multiple chronic immune-mediated conditions.
Built to help reduce friction around treatment access & patient care.
Request Dupixent® (dupilumab injection) sample support and treatment access assistance through DocUpdate Concierge.
Request Samples Through DocUpdate
DocUpdate provides free HIPAA-compliant mobile tools that move care forward.
Frequently Asked Questions About Dupixent Samples
Healthcare providers can download the DocUpdate app and submit a request through Concierge for medication sample and treatment access support.
Dupixent is a monoclonal antibody injection that inhibits IL-4 and IL-13 signaling for several type 2 inflammatory conditions.
Dupixent may be prescribed for indicated conditions such as atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, or COPD depending on patient eligibility.
DocUpdate is designed for licensed healthcare providers with an active NPI number, including physicians, nurse practitioners, and physician assistants.
No. DocUpdate does not dispense medications or provide direct medication fulfillment. The platform helps healthcare providers navigate medication sample support and treatment access resources through Concierge.
Yes. DocUpdate provides free HIPAA-compliant tools and support resources for healthcare providers.